Biotage Beheer
Beheer criteriumcontroles 1/4
We currently do not have sufficient information about the CEO.
Belangrijke informatie
Frederic Vanderhaegen
Algemeen directeur
n/a
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | less than a year |
| Eigendom CEO | n/a |
| Management gemiddelde ambtstermijn | 3.8yrs |
| Gemiddelde ambtstermijn bestuur | 2.9yrs |
Recente managementupdates
Recent updates
Earnings Miss: Biotage AB (publ) Missed EPS By 15% And Analysts Are Revising Their Forecasts
Oct 26
Investors Interested In Biotage AB (publ)'s (STO:BIOT) Earnings
Sep 17Biotage AB (publ) Just Missed EPS By 7.7%: Here's What Analysts Think Will Happen Next
Jul 19Are Investors Undervaluing Biotage AB (publ) (STO:BIOT) By 39%?
Jun 08Is Biotage AB (publ) (STO:BIOT) Potentially Undervalued?
May 21Revenue Beat: Biotage AB (publ) Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates
Apr 28Biotage's (STO:BIOT) Dividend Will Be SEK1.60
Apr 17Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next
Apr 08Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60
Apr 03Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60
Mar 04Weak Statutory Earnings May Not Tell The Whole Story For Biotage (STO:BIOT)
Feb 22Subdued Growth No Barrier To Biotage AB (publ) (STO:BIOT) With Shares Advancing 32%
Feb 21Biotage AB (publ) Just Recorded A 53% EPS Beat: Here's What Analysts Are Forecasting Next
Feb 18Biotage (STO:BIOT) Has A Pretty Healthy Balance Sheet
Feb 08Investors Still Waiting For A Pull Back In Biotage AB (publ) (STO:BIOT)
Jan 07At kr124, Is It Time To Put Biotage AB (publ) (STO:BIOT) On Your Watch List?
Dec 08Estimating The Intrinsic Value Of Biotage AB (publ) (STO:BIOT)
Oct 27Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?
Jul 12An Intrinsic Calculation For Biotage AB (publ) (STO:BIOT) Suggests It's 26% Undervalued
Jun 08Biotage (STO:BIOT) Ticks All The Boxes When It Comes To Earnings Growth
May 24Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 05These 4 Measures Indicate That Biotage (STO:BIOT) Is Using Debt Safely
Mar 12Is It Too Late To Consider Buying Biotage AB (publ) (STO:BIOT)?
Feb 21Are Biotage AB (publ) (STO:BIOT) Investors Paying Above The Intrinsic Value?
Jan 06Biotage (STO:BIOT) Seems To Use Debt Rather Sparingly
Dec 03Is Now The Time To Look At Buying Biotage AB (publ) (STO:BIOT)?
Oct 27Estimating The Fair Value Of Biotage AB (publ) (STO:BIOT)
Oct 07Biotage (STO:BIOT) Could Easily Take On More Debt
Sep 03Is There Now An Opportunity In Biotage AB (publ) (STO:BIOT)?
Jul 10A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)
Jun 25Do Biotage's (STO:BIOT) Earnings Warrant Your Attention?
May 28Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 23CEO
Frederic Vanderhaegen (57 yo)
less than a year
Tenure
Mr. Frederic Vanderhaegen is Chief Executive Officer & President of Biotage AB (publ) from September 16, 2024. Mr. Vanderhaegen joined the Biotage AB (publ) on September 16, 2024. Mr. Frederic was Executiv...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chief Executive Officer & President | less than a year | geen gegevens | geen gegevens | |
| Chief Financial Officer | 1.2yrs | geen gegevens | geen gegevens | |
| Executive Vice President of Operations | 14.5yrs | geen gegevens | 0.0064% SEK 814.6k | |
| EVP of Global Marketing | no data | geen gegevens | geen gegevens | |
| Chief Human Resources & Sustainability Officer | no data | geen gegevens | 0.019% SEK 2.4m | |
| President of Americas & Chief/Head of Americas | no data | geen gegevens | 0.010% SEK 1.3m | |
| Chief Auditor | no data | geen gegevens | geen gegevens | |
| Executive Vice President of Business Development | no data | geen gegevens | 0.025% SEK 3.2m | |
| President of International - EMEA and APAC | 4.4yrs | geen gegevens | 0.0064% SEK 814.6k | |
| Executive Vice President of IT & Digitalization | no data | geen gegevens | 0.0059% SEK 743.5k | |
| Executive Vice President of Quality Assurance & Regulatory Affairs | 3.8yrs | geen gegevens | geen gegevens | |
| Executive Vice President R&D | no data | geen gegevens | geen gegevens |
3.8yrs
Gemiddelde duur
52.5yo
Gemiddelde leeftijd
Ervaren management: BIOT's management team is considered experienced (3.8 years average tenure).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Director | 5yrs | SEK 857.00k | 0.40% SEK 50.8m | |
| Chairman | 1.6yrs | SEK 227.00k | geen gegevens | |
| Director | 11.6yrs | SEK 407.00k | 0.020% SEK 2.5m | |
| Director | 5yrs | SEK 337.00k | geen gegevens | |
| Director | 5.6yrs | SEK 307.00k | geen gegevens | |
| Director | 1.6yrs | geen gegevens | geen gegevens | |
| Employee Representative Director | 2.9yrs | geen gegevens | geen gegevens | |
| Director | 2.6yrs | SEK 357.00k | geen gegevens | |
| Employee Representative Director | no data | geen gegevens | geen gegevens | |
| Employee Representative Director | less than a year | geen gegevens | geen gegevens |
2.9yrs
Gemiddelde duur
61.5yo
Gemiddelde leeftijd
Ervaren bestuur: BIOT's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.